Response to Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin"

J Med Toxicol. 2023 Jul;19(3):309. doi: 10.1007/s13181-023-00940-8. Epub 2023 Mar 29.

Authors

Morganne Sindelar¹, Daniel McCabe², Elisabeth Carroll³

Affiliations

¹ The University of Iowa Hospitals & Clinics, Iowa City, IA, USA. morganne-sindelar@uiowa.edu.
² Division of Medical Toxicology, Department of Emergency Medicine, The University of Iowa Hospitals & Clinics, Iowa City, IA, USA.
³ The University of Iowa Hospitals & Clinics, Iowa City, IA, USA.

PMID: 36988815
PMCID: PMC10054203 (available on 2024-07-01)
DOI: 10.1007/s13181-023-00940-8

No abstract available

Keywords: Drug-drug interaction; Nirmatrelvir/ritonavir; Tacrolimus.

Publication types

Letter
Comment

MeSH terms

Humans
Phenytoin*
Ritonavir* / therapeutic use
Tacrolimus

Substances

Ritonavir
Phenytoin
nirmatrelvir
Tacrolimus